Market size was valued at US$ 234 million in 2024 and is projected to reach US$ 523 million by 2032, at a CAGR of 12.3% during the forecast period 20252032
Report Studies
• The global Piezoelectric and Magnetostrictive Biosensors Market size was valued at US$ 234 million in 2024 and is projected to reach US$ 523 million by 2032, at a CAGR of 12.3% during the forecast period 2025-2032. While the U.S. market accounted for an estimated USD 320 million in 2024, China is expected to grow at a faster pace, reaching USD 420 million by 2032.
• Piezoelectric biosensors convert mechanical energy into electrical signals when detecting biological interactions, whereas magnetostrictive biosensors measure changes in magnetic properties caused by biomolecular binding events. These advanced sensing technologies are widely utilized in medical diagnostics, food safety testing, and industrial monitoring due to their high sensitivity and realtime detection capabilities. The market is segmented into piezoelectric biosensors, which dominate with over 65% share, and magnetostrictive biosensors gaining traction in specialized applications.
By Type:
• The market is segmented based on type into:
• Piezoelectric Biosensors
• Subtypes: Quartz Crystal Microbalance (QCM), Surface Acoustic Wave (SAW), and others
• Magnetostrictive Biosensors
• Subtypes: Microcantilever-based, Thinfilm based, and others
• Hybrid Biosensors
By
Application:
• The market is segmented based on application into:
• Medical
• Subtypes: Disease diagnostics, Drug discovery, and Point-of-care testing
• Food
• Subtypes: Pathogen detection, Food quality monitoring
• Industrial
• Environmental monitoring
• Others
• Biolin Scientific (Addlife) (Sweden)
• AWSensors (Spain)
• Quartz Pro (Sweden)
• INFICON (Switzerland)
• MicroVacuum (Hungary)
• 3T analytik (Germany)
• Gamry Instruments (U.S.)
